SNCA and Parkinson disease: In a Parkinson’s disease (PD), a disease reported in 1817 by James Parkinson [21], EVs contributed to the spread of disease [5], since aggregated α-synuclein has been detected in many fluids, including brain interstitial fluid and cerebral spinal fluid [5,13,22,23,24,25].